442 related articles for article (PubMed ID: 26537686)
21. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
Boon AC; de Mutsert G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2006 Jun; 80(12):6024-32. PubMed ID: 16731941
[TBL] [Abstract][Full Text] [Related]
22. Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.
Bodewes R; Geelhoed-Mieras MM; Nieuwkoop NJ; Hanson JA; David CS; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Virus Res; 2011 Jan; 155(1):123-30. PubMed ID: 20863862
[TBL] [Abstract][Full Text] [Related]
23. Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.
Ichihashi T; Yoshida R; Sugimoto C; Takada A; Kajino K
PLoS One; 2011; 6(9):e24626. PubMed ID: 21949735
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease.
Herrmann VL; Hartmayer C; Planz O; Groettrup M
J Control Release; 2015 Oct; 216():121-31. PubMed ID: 26276509
[TBL] [Abstract][Full Text] [Related]
25. Single-Cell Approach to Influenza-Specific CD8
Sant S; Grzelak L; Wang Z; Pizzolla A; Koutsakos M; Crowe J; Loudovaris T; Mannering SI; Westall GP; Wakim LM; Rossjohn J; Gras S; Richards M; Xu J; Thomas PG; Loh L; Nguyen THO; Kedzierska K
Front Immunol; 2018; 9():1453. PubMed ID: 29997621
[TBL] [Abstract][Full Text] [Related]
26. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
[TBL] [Abstract][Full Text] [Related]
27. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.
Berkhoff EG; Geelhoed-Mieras MM; Verschuren EJ; van Baalen CA; Gruters RA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Clin Exp Immunol; 2007 May; 148(2):296-306. PubMed ID: 17326762
[TBL] [Abstract][Full Text] [Related]
28. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
[TBL] [Abstract][Full Text] [Related]
29. [The impact of conservative and hypervariable immunodominant epitopes in internal proteins of the influenza A virus on cytotoxic T-cell immune responses].
Naikhin AN; Losev IV
Vopr Virusol; 2015; 60(1):11-6. PubMed ID: 26021066
[TBL] [Abstract][Full Text] [Related]
30. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
Carreno BM; Turner RV; Biddison WE; Coligan JE
J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
[TBL] [Abstract][Full Text] [Related]
31. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
Boon AC; de Mutsert G; van Baarle D; Smith DJ; Lapedes AS; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Immunol; 2004 Feb; 172(4):2453-60. PubMed ID: 14764717
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.
Berkhoff EGM; Geelhoed-Mieras MM; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
J Gen Virol; 2007 Feb; 88(Pt 2):530-535. PubMed ID: 17251571
[TBL] [Abstract][Full Text] [Related]
33. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
Cheuk E; Chamberlain JW
Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
[TBL] [Abstract][Full Text] [Related]
34. Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses.
Grant E; Wu C; Chan KF; Eckle S; Bharadwaj M; Zou QM; Kedzierska K; Chen W
Immunol Cell Biol; 2013 Feb; 91(2):184-94. PubMed ID: 23399741
[TBL] [Abstract][Full Text] [Related]
35. T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.
Wahl A; McCoy WH; Schafer F; Bardet W; Buchli R; Fremont DH; Hildebrand WH
J Virol; 2009 Sep; 83(18):9206-14. PubMed ID: 19553306
[TBL] [Abstract][Full Text] [Related]
36. Epitope specific T-cell responses against influenza A in a healthy population.
Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
[TBL] [Abstract][Full Text] [Related]
37. Immunodominance of a single CTL epitope in a primate species with limited MHC class I polymorphism.
Evans DT; Piekarczyk MS; Allen TM; Boyson JE; Yeager M; Hughes AL; Gotch FM; Hinshaw VS; Watkins DI
J Immunol; 1997 Aug; 159(3):1374-82. PubMed ID: 9233634
[TBL] [Abstract][Full Text] [Related]
38. Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.
Szurgot I; Szolajska E; Laurin D; Lambrecht B; Chaperot L; Schoehn G; Chroboczek J
Vaccine; 2013 Sep; 31(40):4338-46. PubMed ID: 23880363
[TBL] [Abstract][Full Text] [Related]
39. Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures.
Grant EJ; Josephs TM; Valkenburg SA; Wooldridge L; Hellard M; Rossjohn J; Bharadwaj M; Kedzierska K; Gras S
J Biol Chem; 2016 Nov; 291(47):24335-24351. PubMed ID: 27645996
[TBL] [Abstract][Full Text] [Related]
40. Human cytotoxic T-lymphocyte repertoire to influenza A viruses.
Jameson J; Cruz J; Ennis FA
J Virol; 1998 Nov; 72(11):8682-9. PubMed ID: 9765409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
